Ligand Pharmaceuticals Incorporated LGND
314.15 USD +7.95 (+2.60%)
At closeNov 9, 2026, 4:01 PM EST
314.15 0.00 0.00%
After hours · Nov 9, 4:01 PM ET
307.17 Day range 315.80
175.89 52-week range 326.63
- YTD
- +66.16%
- 1 year
- +55.15%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 268.09M | 167.13M | 131.31M | 196.25M | 241.54M | |
| 253.54M | 156.06M | 120.80M | 143.42M | 179.37M | |
| 41.00M | -22.61M | 11.94M | 3.04M | 103.85M | |
| 124.45M | -4.03M | 52.15M | -33.36M | 57.14M | |
| 6.13 | -0.22 | 2.94 | -1.98 | 3.31 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 174.93M | 72.31M | 22.95M | 45.01M | 19.52M | |
| 1.56B | 941.77M | 787.22M | 762.67M | 1.30B | |
| 543.42M | 111.33M | 86.30M | 165.18M | 476.43M | |
| 451.49M | 7.08M | 6.17M | 87.75M | 324.39M | |
| 1.02B | 830.44M | 700.91M | 597.49M | 821.16M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 49.36M | 97.05M | 49.58M | 137.85M | 78.80M | |
| -377.32M | -143.66M | -11.68M | 163.62M | 30.52M | |
| 428.22M | 97.14M | -59.95M | -275.99M | -137.76M | |
| -1.26M | -1.82M | -3.52M | -17.92M | -8.27M | |
| 102.62M | 49.35M | -22.05M | 25.48M | -28.44M |